Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
Clinical trial NCT06913023 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06913023
- Sponsor
- University Health Network, Toronto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2027-11-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.